论文部分内容阅读
目的探讨缬沙坦联合氨氯地平治疗社区老年高血压伴2型糖尿病患者的临床疗效。方法收集2011年1月至2014年7月我院收治的280例社区老年高血压伴2型糖尿病患者临床资料,将患者采用随机数字表法分为研究组和对照组,各140例,研究组患者给予缬沙坦联合氨氯地平治疗,对照组患者单纯给予氨氯地平治疗,综合比较两组患者治疗前后收缩压(SBP)、舒张压(DBP)、空腹血糖(FBG)、餐后2 h血糖(2 h PG)、空腹胰岛素(FINS)及胰岛素敏感指数(ISI)变化情况。结果治疗后研究组患者血压低于对照组;且研究组患者FBG、2 h PG、FINS及ISI水平均优于对照组(均P<0.05)。结论缬沙坦联合氨氯地平治疗社区老年高血压伴2型糖尿病效果确切,可有效降低血压,控制血糖水平。
Objective To investigate the clinical efficacy of valsartan combined with amlodipine in the treatment of elderly hypertensive patients with type 2 diabetes in community. Methods The clinical data of 280 elderly hypertensive patients with type 2 diabetes mellitus admitted to our hospital from January 2011 to July 2014 were collected. The patients were divided into study group and control group by random number table, and each group of 140 patients, study group Patients were given valsartan combined with amlodipine, and patients in control group were treated with amlodipine alone. The SBP, DBP, FBG, Blood glucose (2 h PG), fasting insulin (FINS) and insulin sensitivity index (ISI) changes. Results After treatment, the blood pressure of the study group was lower than that of the control group. The levels of FBG, 2 h PG, FINS and ISI in the study group were better than those in the control group (all P <0.05). Conclusion Valsartan combined with amlodipine has the exact effect in treating elderly type 2 diabetes mellitus with community hypertension, which can effectively lower blood pressure and control blood sugar level.